The identification of non-coding somatic cancer-driver mutations remains challenging due to difficulties in interpreting rare and ultra-rare variants. We hypothesized that sequence-based models can be used to systematically prioritize such mutations for their functional relevance.
Here, we developed a comp...
Tijs van Lieshout, C. G. Urzúa-Traslaviña, Lucía Barbadilla-Martínez et al.· Genome Medicine· 0 citations
Multi-omic profiling of blood immune cells revealed novel immune signatures associated with CAD, short- and long-term cardiovascular disease outcomes that are independent of systemic inflammation and may be used as risk stratification tools in the future.
H. Horstmann, N. Anto-Michel, C. Losert et al.· European Heart Journal· 0 citations
Human genetic studies have identified key regulators of fetal haemoglobin (HbF) expression, including BCL11A, resulting in therapeutic advances1-8. Yet the mechanisms by which HbF expression is activated remain incompletely understood9. Here we conduct a large multi-ancestry genome-wide association study of HbF levels...
Chun-Jie Guo, U. Arora, Xiao-Heng Cheng et al.· Nature· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.